Got $2,000: Invest in These 2 Cheap TSX Stocks to Double Your Money

Despite their near-term risks, both BlackBerry and Canopy Growth offer strong long-term growth potential.

| More on:

The Canadian financial markets have recovered strongly from their March lows. However, some of the stocks are still struggling and are trading at attractive valuations. So, if you have the appetite for risk-taking and can stay invested for extended periods, I believe these two stocks could deliver huge profits.

BlackBerry

When the majority of the tech companies have delivered excellent returns this year, BlackBerry (TSX:BB)(NYSE:BB) is struggling with its stock, trading over 24% lower. The company’s significant exposure to the automotive industry impacted its financials in its recently completed first quarter.

Its adjusted revenue declined by 19.9% on a year-over-year basis. The global auto production shutdowns and project delays amid the pandemic had dragged the company’s revenue down. However, with the reopening of the economies, the auto sector is beginning to recover.

The company also provides cybersecurity solutions for companies across various sectors. With the rise in the number of employees working from their homes, the demand for data safety and privacy solutions has increased, which could benefit BlackBerry.

At the end of its first quarter, the company’s cash, cash equivalents, and investments stood at US$955 million. Further, the company’s management expects its free cash flow to be positive for this fiscal year. So, the company’s liquidity position looks secure. Given its attractive valuation, strong balance sheet, and growth prospects, I believe investors with a long-term horizon should buy the stock for higher gains.

Canopy Growth

My second pick is a cannabis company Canopy Growth (TSX:WEED)(NYSE:CGC), which has lost over 20% of its stock value this year. Although the cannabis sector is facing structural issues, the company had outperformed analysts’ sales expectations in its recently reported first-quarter results.

Its revenues came in at $110.4 million against analysts’ expectations of $93.5 million. The growth in medical sales offset the decline in recreational sales to drive the company’s revenue. The increased competition and the temporary closure of retail stores due to the pandemic dragged the company’s recreational sales down.

However, Canopy Growth has re-positioned its value brand Tweed dried flower with higher and more consistent THC ranges and is working on expanding its Cannabis 2.0 offerings in Canada to drive its recreational sales. In the United States, the company has increased its online presence by launching an e-commerce site, which sells all brands of CBD products from Canopy growth.

The company has also scaled up the distribution of its S&B vaporizer and BioSteel RTD non-CBD beverages to some of the key markets in the United States. All these initiatives could drive the company’s top line.

Meanwhile, its adjusted EBITDA is still in negative territory, which is a cause of concern. The company is working on lowering its expenditures. Year to date, the company has reduced its headcount by 18%. Further, it has optimized its production by closing two of its facilities in British Columbia and one indoor facility in Saskatchewan. Along with these cost-cutting initiatives, the growth in higher-margin Cannabis 2.0 product sales could aid the company in attaining profitability.

Moreover, in its first quarter, the company reduced its cash burn by 50% to $180.1 million. At the end of the quarter, the company’s gross cash stood at $2 billion. So, given its strong growth potential, improving margins, and strong balance sheet, I believe Canopy Growth’s stock could double over the next three years.

The Motley Fool recommends BlackBerry and BlackBerry. Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

More on Cannabis Stocks

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »